|
|
Canaccord Genuity Maintains Buy on GRAIL, Lowers Price Target to $80
|
|
|
|
12 Health Care Stocks Moving In Friday's Intraday Session
|
|
|
|
Baird Maintains Outperform on GRAIL, Lowers Price Target to $82
|
|
|
|
Nasdaq Gains 1%; PPL Posts In-Line Q4 Earnings
|
|
|
|
Supreme Court Rules Against Trump's Tariffs: These 10 Stocks Are Soaring
|
|
|
|
Dow Rises Over 100 Points; US GDP Growth Slows In Q4
|
|
|
|
Stock Market Today: Dow Jones, S&P 500 Futures Slip After Weaker-Than-Expected GDP Report—Grail, Candel Therapeutics, Copart In Focus (UPDATED)
|
|
|
|
GRAIL shares are trading lower after the company reported worse-than-expected Q4 sales results. Topline results for HS-Galleri Trial did not meet its primary endpoint of statistically significant Stage III-IV reduction.
|
|
|
|
Akamai Technologies, Inseego, Ardelyx And Other Big Stocks Moving Lower In Friday's Pre-Market Session
|
|
|
|
Market-Moving News for February 20th
|
|